share_log

Cybin Says CYB003 Showed Clear Incremental Benefit Of Second Dose, Resulting In 4 Out Of 5 Patients In Remission From Their Depression At 6 Weeks

Benzinga ·  Nov 30, 2023 07:36

At 6 weeks, incremental MADRS score reductions were seen with 79% of patients in remission from depression after just two doses of CYB003 (12mg).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment